| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelial Cells | 40 | 2022 | 308 | 11.300 |
Why?
|
| Mechanotransduction, Cellular | 32 | 2021 | 48 | 10.990 |
Why?
|
| Glycocalyx | 35 | 2021 | 36 | 10.080 |
Why?
|
| Endothelium, Vascular | 32 | 2021 | 237 | 6.900 |
Why?
|
| Stress, Mechanical | 43 | 2021 | 113 | 5.760 |
Why?
|
| Models, Cardiovascular | 20 | 2016 | 49 | 4.090 |
Why?
|
| Atherosclerosis | 10 | 2022 | 134 | 3.510 |
Why?
|
| Glypicans | 7 | 2021 | 8 | 3.430 |
Why?
|
| Myocytes, Smooth Muscle | 10 | 2015 | 86 | 3.050 |
Why?
|
| Nitric Oxide | 17 | 2021 | 316 | 2.840 |
Why?
|
| Aorta | 16 | 2015 | 167 | 2.690 |
Why?
|
| Heparan Sulfate Proteoglycans | 6 | 2019 | 12 | 2.650 |
Why?
|
| Muscle, Smooth, Vascular | 11 | 2015 | 130 | 2.460 |
Why?
|
| Shear Strength | 15 | 2017 | 25 | 2.160 |
Why?
|
| Cell Movement | 7 | 2019 | 571 | 2.030 |
Why?
|
| Cells, Cultured | 36 | 2021 | 1518 | 2.010 |
Why?
|
| Cattle | 28 | 2016 | 477 | 2.010 |
Why?
|
| Animals | 76 | 2022 | 15081 | 1.950 |
Why?
|
| Lipoproteins, LDL | 7 | 2016 | 62 | 1.910 |
Why?
|
| Heparitin Sulfate | 10 | 2019 | 23 | 1.820 |
Why?
|
| Models, Biological | 13 | 2018 | 677 | 1.540 |
Why?
|
| Syndecan-1 | 6 | 2019 | 9 | 1.520 |
Why?
|
| Nitric Oxide Synthase Type III | 9 | 2021 | 67 | 1.450 |
Why?
|
| Capillary Permeability | 7 | 2016 | 30 | 1.440 |
Why?
|
| Extracellular Fluid | 3 | 2019 | 13 | 1.410 |
Why?
|
| Glycosaminoglycans | 6 | 2018 | 22 | 1.320 |
Why?
|
| Lysophospholipids | 6 | 2018 | 19 | 1.270 |
Why?
|
| Rats | 28 | 2021 | 3483 | 1.200 |
Why?
|
| Arteries | 6 | 2020 | 65 | 1.170 |
Why?
|
| Matrix Metalloproteinase 1 | 3 | 2011 | 22 | 1.090 |
Why?
|
| Computer Simulation | 8 | 2017 | 362 | 1.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2011 | 103 | 1.070 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 1015 | 1.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2011 | 99 | 1.060 |
Why?
|
| Sphingosine | 5 | 2018 | 21 | 1.010 |
Why?
|
| Endothelium | 3 | 2016 | 31 | 1.010 |
Why?
|
| Blood Flow Velocity | 11 | 2015 | 61 | 1.000 |
Why?
|
| Water | 10 | 2023 | 296 | 0.950 |
Why?
|
| Integrins | 3 | 2019 | 51 | 0.920 |
Why?
|
| Biological Transport | 13 | 2018 | 185 | 0.910 |
Why?
|
| Fibroblasts | 3 | 2011 | 272 | 0.890 |
Why?
|
| Aorta, Thoracic | 7 | 2016 | 28 | 0.880 |
Why?
|
| Neoplasm Metastasis | 3 | 2019 | 219 | 0.830 |
Why?
|
| Endothelin-1 | 3 | 2007 | 55 | 0.800 |
Why?
|
| Astrocytes | 2 | 2022 | 255 | 0.790 |
Why?
|
| Hemodynamics | 10 | 2016 | 91 | 0.770 |
Why?
|
| Vascular Diseases | 1 | 2021 | 30 | 0.770 |
Why?
|
| Apoptosis | 6 | 2016 | 1398 | 0.760 |
Why?
|
| Rheology | 5 | 2014 | 25 | 0.740 |
Why?
|
| Mice | 13 | 2022 | 5913 | 0.730 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2011 | 47 | 0.730 |
Why?
|
| Membrane Microdomains | 3 | 2018 | 47 | 0.720 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2019 | 36 | 0.710 |
Why?
|
| Humans | 41 | 2022 | 37093 | 0.710 |
Why?
|
| Gene Expression | 3 | 2022 | 674 | 0.690 |
Why?
|
| Syndecan-4 | 1 | 2019 | 4 | 0.690 |
Why?
|
| Kidney Neoplasms | 2 | 2019 | 68 | 0.690 |
Why?
|
| Heart Valve Prosthesis | 6 | 2005 | 18 | 0.690 |
Why?
|
| Cell Communication | 3 | 2017 | 97 | 0.690 |
Why?
|
| Calcium Signaling | 3 | 2005 | 101 | 0.680 |
Why?
|
| Pulsatile Flow | 5 | 2015 | 14 | 0.680 |
Why?
|
| Epoprostenol | 2 | 2016 | 25 | 0.650 |
Why?
|
| Electroosmosis | 1 | 2018 | 1 | 0.650 |
Why?
|
| Stress, Physiological | 2 | 2017 | 150 | 0.630 |
Why?
|
| Cyclooxygenase 2 | 2 | 2016 | 104 | 0.610 |
Why?
|
| Coronary Vessels | 4 | 2016 | 85 | 0.600 |
Why?
|
| Blood Pressure | 9 | 2013 | 646 | 0.600 |
Why?
|
| Cytoskeleton | 4 | 2014 | 110 | 0.590 |
Why?
|
| Transcription Factor RelA | 1 | 2016 | 40 | 0.570 |
Why?
|
| Intercellular Junctions | 4 | 2010 | 17 | 0.540 |
Why?
|
| Hemorheology | 6 | 2006 | 8 | 0.530 |
Why?
|
| Matrix Metalloproteinase 13 | 2 | 2013 | 5 | 0.500 |
Why?
|
| Cell Line | 7 | 2018 | 1354 | 0.490 |
Why?
|
| Microcirculation | 4 | 2014 | 37 | 0.470 |
Why?
|
| Blood-Retinal Barrier | 2 | 2011 | 8 | 0.470 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 664 | 0.470 |
Why?
|
| Diabetic Angiopathies | 1 | 2013 | 21 | 0.460 |
Why?
|
| Membrane Fluidity | 1 | 2013 | 11 | 0.460 |
Why?
|
| Cell Adhesion | 4 | 2017 | 212 | 0.450 |
Why?
|
| Hyaluronic Acid | 4 | 2017 | 33 | 0.440 |
Why?
|
| Chondroitin Sulfates | 4 | 2015 | 9 | 0.430 |
Why?
|
| Collagen Type I | 2 | 2009 | 30 | 0.430 |
Why?
|
| Heart, Artificial | 4 | 2004 | 6 | 0.420 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2016 | 1618 | 0.420 |
Why?
|
| Pressure | 9 | 2010 | 43 | 0.410 |
Why?
|
| Cell Membrane Permeability | 4 | 2018 | 52 | 0.410 |
Why?
|
| Permeability | 6 | 2011 | 67 | 0.400 |
Why?
|
| RNA, Small Interfering | 4 | 2021 | 409 | 0.400 |
Why?
|
| Albumins | 2 | 2012 | 26 | 0.400 |
Why?
|
| Nitric Oxide Synthase | 3 | 2013 | 128 | 0.400 |
Why?
|
| Polysaccharide-Lyases | 5 | 2015 | 10 | 0.390 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 115 | 0.390 |
Why?
|
| Retinal Vessels | 1 | 2011 | 24 | 0.390 |
Why?
|
| Cryopreservation | 1 | 2011 | 25 | 0.390 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 59 | 0.390 |
Why?
|
| Capillaries | 4 | 2012 | 26 | 0.380 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2011 | 19 | 0.380 |
Why?
|
| Arterioles | 3 | 2015 | 19 | 0.380 |
Why?
|
| Chemotaxis | 2 | 2011 | 60 | 0.380 |
Why?
|
| Proteoglycans | 3 | 2018 | 47 | 0.380 |
Why?
|
| Vasa Vasorum | 2 | 2020 | 3 | 0.370 |
Why?
|
| Glioma | 1 | 2011 | 79 | 0.370 |
Why?
|
| Algorithms | 4 | 2006 | 465 | 0.370 |
Why?
|
| Cell Membrane | 3 | 2014 | 381 | 0.370 |
Why?
|
| Body Fluids | 1 | 2010 | 17 | 0.370 |
Why?
|
| Finite Element Analysis | 3 | 2020 | 16 | 0.360 |
Why?
|
| Antigens, CD | 3 | 2016 | 121 | 0.360 |
Why?
|
| Hyperglycemia | 1 | 2011 | 55 | 0.360 |
Why?
|
| Mitosis | 1 | 2010 | 99 | 0.350 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2009 | 26 | 0.350 |
Why?
|
| Membrane Proteins | 4 | 2011 | 517 | 0.350 |
Why?
|
| Microscopy, Atomic Force | 2 | 2021 | 60 | 0.340 |
Why?
|
| Cholesterol, LDL | 1 | 2009 | 68 | 0.340 |
Why?
|
| Cell Proliferation | 2 | 2021 | 1198 | 0.320 |
Why?
|
| Phosphorylation | 3 | 2021 | 928 | 0.320 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 2231 | 0.320 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2011 | 161 | 0.320 |
Why?
|
| Time Factors | 7 | 2016 | 1742 | 0.320 |
Why?
|
| Cholesterol | 2 | 2016 | 205 | 0.320 |
Why?
|
| RNA Interference | 4 | 2016 | 243 | 0.320 |
Why?
|
| Mice, Knockout | 2 | 2021 | 933 | 0.310 |
Why?
|
| Cell Culture Techniques | 4 | 2013 | 142 | 0.310 |
Why?
|
| Up-Regulation | 4 | 2016 | 513 | 0.310 |
Why?
|
| Mesentery | 2 | 2016 | 9 | 0.300 |
Why?
|
| Male | 18 | 2022 | 20025 | 0.300 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 2007 | 2 | 0.300 |
Why?
|
| Diffusion | 5 | 2015 | 50 | 0.290 |
Why?
|
| Muscle Contraction | 2 | 2004 | 66 | 0.290 |
Why?
|
| Transport Vesicles | 1 | 2007 | 21 | 0.290 |
Why?
|
| Regional Blood Flow | 4 | 2020 | 40 | 0.290 |
Why?
|
| Carotid Sinus | 1 | 2006 | 1 | 0.290 |
Why?
|
| Adherens Junctions | 2 | 2017 | 8 | 0.270 |
Why?
|
| Oxygen Consumption | 1 | 2006 | 103 | 0.270 |
Why?
|
| Intracellular Fluid | 1 | 2005 | 26 | 0.270 |
Why?
|
| Umbilical Veins | 1 | 2005 | 17 | 0.270 |
Why?
|
| Gels | 3 | 2011 | 42 | 0.270 |
Why?
|
| Phenotype | 3 | 2016 | 689 | 0.250 |
Why?
|
| Serum | 1 | 2004 | 15 | 0.250 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2016 | 90 | 0.250 |
Why?
|
| Actins | 3 | 2014 | 148 | 0.240 |
Why?
|
| Serum Albumin, Bovine | 1 | 2004 | 51 | 0.240 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 41 | 0.240 |
Why?
|
| Elastic Tissue | 1 | 2004 | 7 | 0.240 |
Why?
|
| Protein Binding | 2 | 2021 | 972 | 0.240 |
Why?
|
| Adipose Tissue | 2 | 2017 | 177 | 0.240 |
Why?
|
| Blood Circulation | 1 | 2003 | 2 | 0.240 |
Why?
|
| Homeostasis | 1 | 2005 | 188 | 0.230 |
Why?
|
| Membranes, Artificial | 1 | 2003 | 28 | 0.230 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 1371 | 0.230 |
Why?
|
| Water-Electrolyte Balance | 1 | 2003 | 17 | 0.230 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 168 | 0.230 |
Why?
|
| Oxygen | 2 | 2020 | 207 | 0.230 |
Why?
|
| Cadherins | 2 | 2014 | 90 | 0.230 |
Why?
|
| Inflammation | 3 | 2022 | 618 | 0.220 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 36 | 0.220 |
Why?
|
| Tissue Distribution | 3 | 2013 | 207 | 0.220 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 196 | 0.220 |
Why?
|
| Neovascularization, Pathologic | 2 | 2020 | 127 | 0.220 |
Why?
|
| Fluorescein | 2 | 2017 | 16 | 0.210 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 626 | 0.210 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2022 | 61 | 0.210 |
Why?
|
| Embolism, Air | 1 | 2002 | 2 | 0.210 |
Why?
|
| Hypertension | 1 | 2009 | 796 | 0.210 |
Why?
|
| Tight Junctions | 4 | 2010 | 24 | 0.200 |
Why?
|
| Neuronal Plasticity | 1 | 2022 | 103 | 0.200 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 173 | 0.200 |
Why?
|
| Laser-Doppler Flowmetry | 4 | 2005 | 10 | 0.200 |
Why?
|
| Collagen | 2 | 2013 | 172 | 0.200 |
Why?
|
| Chondroitinases and Chondroitin Lyases | 2 | 2012 | 2 | 0.190 |
Why?
|
| Dextrans | 4 | 2011 | 21 | 0.190 |
Why?
|
| Hyaluronoglucosaminidase | 2 | 2012 | 20 | 0.190 |
Why?
|
| Lipoproteins | 2 | 2016 | 64 | 0.190 |
Why?
|
| Enzyme Activation | 2 | 2014 | 444 | 0.190 |
Why?
|
| Glucose | 2 | 2013 | 230 | 0.190 |
Why?
|
| Vascular Resistance | 1 | 2020 | 34 | 0.180 |
Why?
|
| Rats, Wistar | 3 | 2005 | 233 | 0.180 |
Why?
|
| Microscopy, Video | 3 | 2005 | 11 | 0.180 |
Why?
|
| Stents | 1 | 2020 | 59 | 0.180 |
Why?
|
| Equipment Failure Analysis | 3 | 2004 | 41 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 4 | 2022 | 1609 | 0.180 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 123 | 0.180 |
Why?
|
| Blotting, Western | 3 | 2011 | 859 | 0.170 |
Why?
|
| Biological Transport, Active | 2 | 2011 | 26 | 0.170 |
Why?
|
| Signal Transduction | 3 | 2016 | 1908 | 0.170 |
Why?
|
| Tissue Engineering | 1 | 2019 | 60 | 0.170 |
Why?
|
| Macromolecular Substances | 3 | 2004 | 96 | 0.170 |
Why?
|
| Hydrostatic Pressure | 4 | 2010 | 7 | 0.160 |
Why?
|
| Microscopy | 2 | 2019 | 32 | 0.160 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 93 | 0.160 |
Why?
|
| Osmotic Pressure | 3 | 2015 | 21 | 0.160 |
Why?
|
| Microvessels | 2 | 2016 | 28 | 0.160 |
Why?
|
| Prosthesis Design | 5 | 2005 | 24 | 0.160 |
Why?
|
| Age Factors | 1 | 2021 | 1033 | 0.150 |
Why?
|
| Enzyme Inhibitors | 3 | 2005 | 433 | 0.150 |
Why?
|
| Cell Division | 2 | 2009 | 307 | 0.150 |
Why?
|
| omega-N-Methylarginine | 2 | 2015 | 4 | 0.150 |
Why?
|
| Blood Proteins | 1 | 2018 | 66 | 0.150 |
Why?
|
| Intracellular Space | 1 | 2017 | 35 | 0.150 |
Why?
|
| Indicators and Reagents | 1 | 2017 | 58 | 0.150 |
Why?
|
| NF-kappa B | 2 | 2022 | 339 | 0.150 |
Why?
|
| Cilia | 1 | 2016 | 27 | 0.140 |
Why?
|
| Sulfotransferases | 1 | 2016 | 7 | 0.140 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2016 | 59 | 0.140 |
Why?
|
| Factor Xa | 1 | 2016 | 3 | 0.140 |
Why?
|
| Spheroids, Cellular | 1 | 2016 | 28 | 0.140 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 21 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 95 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 51 | 0.140 |
Why?
|
| Thrombin | 1 | 2016 | 25 | 0.140 |
Why?
|
| Blood Coagulation | 1 | 2016 | 23 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 623 | 0.140 |
Why?
|
| Tumor Burden | 1 | 2016 | 77 | 0.140 |
Why?
|
| Down-Regulation | 2 | 2011 | 435 | 0.140 |
Why?
|
| Mice, SCID | 1 | 2016 | 150 | 0.140 |
Why?
|
| Biological Assay | 1 | 2016 | 59 | 0.140 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2007 | 26 | 0.140 |
Why?
|
| Coculture Techniques | 2 | 2013 | 101 | 0.140 |
Why?
|
| Tunica Intima | 2 | 2007 | 19 | 0.140 |
Why?
|
| Cell Differentiation | 2 | 2011 | 587 | 0.140 |
Why?
|
| Blood Platelets | 1 | 2016 | 77 | 0.130 |
Why?
|
| Exocytosis | 1 | 2015 | 47 | 0.130 |
Why?
|
| Physical Stimulation | 2 | 2006 | 26 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 502 | 0.130 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 2005 | 36 | 0.130 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2016 | 146 | 0.130 |
Why?
|
| Aquaporin 1 | 1 | 2015 | 8 | 0.130 |
Why?
|
| Reproducibility of Results | 4 | 2016 | 935 | 0.130 |
Why?
|
| Sepsis | 1 | 2015 | 80 | 0.120 |
Why?
|
| Lipids | 1 | 2016 | 235 | 0.120 |
Why?
|
| Focal Adhesions | 1 | 2014 | 15 | 0.120 |
Why?
|
| Blood Cells | 1 | 2014 | 8 | 0.120 |
Why?
|
| Caveolae | 1 | 2014 | 9 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 893 | 0.120 |
Why?
|
| G(M1) Ganglioside | 1 | 2014 | 14 | 0.120 |
Why?
|
| Adaptation, Physiological | 2 | 2005 | 109 | 0.120 |
Why?
|
| Cell Shape | 1 | 2014 | 35 | 0.120 |
Why?
|
| Caveolin 1 | 1 | 2014 | 29 | 0.120 |
Why?
|
| Integrin alpha3 | 1 | 2013 | 1 | 0.120 |
Why?
|
| Rhodamines | 2 | 2011 | 21 | 0.120 |
Why?
|
| Peptides | 1 | 2016 | 320 | 0.120 |
Why?
|
| Anisotropy | 2 | 2020 | 27 | 0.120 |
Why?
|
| Gelatin | 1 | 2013 | 15 | 0.120 |
Why?
|
| Phospholipids | 1 | 2014 | 70 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2014 | 106 | 0.110 |
Why?
|
| Matrix Metalloproteinases | 1 | 2013 | 48 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2014 | 217 | 0.110 |
Why?
|
| Software | 1 | 2014 | 217 | 0.110 |
Why?
|
| Cell Adhesion Molecules | 1 | 2013 | 75 | 0.110 |
Why?
|
| Electric Impedance | 3 | 2010 | 25 | 0.110 |
Why?
|
| Adsorption | 1 | 2012 | 68 | 0.110 |
Why?
|
| Elastic Modulus | 1 | 2012 | 17 | 0.100 |
Why?
|
| Blood Vessels | 1 | 2012 | 34 | 0.100 |
Why?
|
| Histocytochemistry | 1 | 2011 | 50 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 252 | 0.100 |
Why?
|
| Chemotactic Factors | 1 | 2011 | 7 | 0.100 |
Why?
|
| Freeze Substitution | 1 | 2011 | 1 | 0.100 |
Why?
|
| Body Water | 1 | 2011 | 26 | 0.100 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 133 | 0.090 |
Why?
|
| Fluorescence | 1 | 2011 | 121 | 0.090 |
Why?
|
| Binding Sites | 1 | 2012 | 651 | 0.090 |
Why?
|
| Paclitaxel | 1 | 2010 | 50 | 0.090 |
Why?
|
| Cell Survival | 2 | 2011 | 864 | 0.090 |
Why?
|
| Calcium | 2 | 2004 | 480 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 251 | 0.090 |
Why?
|
| Microscopy, Confocal | 4 | 2015 | 218 | 0.090 |
Why?
|
| Genes, fos | 1 | 2009 | 14 | 0.090 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2009 | 9 | 0.090 |
Why?
|
| Flavonoids | 1 | 2010 | 87 | 0.090 |
Why?
|
| Diet | 1 | 2016 | 801 | 0.090 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2009 | 8 | 0.090 |
Why?
|
| Transcription Factor AP-1 | 1 | 2009 | 35 | 0.090 |
Why?
|
| Cycloheximide | 1 | 2009 | 30 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 197 | 0.090 |
Why?
|
| Polymers | 1 | 2010 | 121 | 0.090 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2009 | 14 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 448 | 0.090 |
Why?
|
| Cell Separation | 1 | 2009 | 93 | 0.090 |
Why?
|
| Heparin Lyase | 1 | 2009 | 2 | 0.090 |
Why?
|
| Pronase | 1 | 2009 | 4 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2011 | 305 | 0.090 |
Why?
|
| Dipeptides | 1 | 2009 | 32 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2012 | 173 | 0.080 |
Why?
|
| Protease Inhibitors | 1 | 2009 | 49 | 0.080 |
Why?
|
| Necrosis | 1 | 2009 | 49 | 0.080 |
Why?
|
| DNA Primers | 1 | 2009 | 286 | 0.080 |
Why?
|
| Mitral Valve | 2 | 2005 | 19 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2009 | 151 | 0.080 |
Why?
|
| Enzymes | 1 | 2008 | 32 | 0.080 |
Why?
|
| Blood-Brain Barrier | 1 | 2010 | 162 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 400 | 0.080 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2008 | 33 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 807 | 0.080 |
Why?
|
| RNA | 1 | 2009 | 241 | 0.080 |
Why?
|
| Nitrates | 2 | 2010 | 40 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2004 | 61 | 0.070 |
Why?
|
| Smooth Muscle Myosins | 1 | 2007 | 1 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2007 | 8 | 0.070 |
Why?
|
| Materials Testing | 2 | 2005 | 69 | 0.070 |
Why?
|
| Connective Tissue | 1 | 2007 | 9 | 0.070 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2007 | 7 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 356 | 0.070 |
Why?
|
| Myosin Heavy Chains | 1 | 2007 | 19 | 0.070 |
Why?
|
| Prosthesis Failure | 2 | 2003 | 8 | 0.070 |
Why?
|
| Hyperplasia | 1 | 2007 | 38 | 0.070 |
Why?
|
| Computational Biology | 1 | 2009 | 293 | 0.070 |
Why?
|
| PPAR alpha | 1 | 2007 | 42 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2007 | 53 | 0.070 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2005 | 61 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2003 | 562 | 0.070 |
Why?
|
| Elasticity | 2 | 2007 | 38 | 0.070 |
Why?
|
| Brain | 3 | 2023 | 1346 | 0.070 |
Why?
|
| Models, Chemical | 1 | 2007 | 207 | 0.070 |
Why?
|
| Rabbits | 1 | 2006 | 283 | 0.070 |
Why?
|
| Surface Properties | 1 | 2006 | 130 | 0.070 |
Why?
|
| Blood Volume | 1 | 2005 | 5 | 0.070 |
Why?
|
| Xanthenes | 1 | 2005 | 11 | 0.070 |
Why?
|
| Acoustics | 1 | 2005 | 15 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2004 | 112 | 0.060 |
Why?
|
| Carbon Dioxide | 1 | 2005 | 77 | 0.060 |
Why?
|
| Flow Injection Analysis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Sonication | 1 | 2004 | 16 | 0.060 |
Why?
|
| Osmosis | 1 | 2004 | 8 | 0.060 |
Why?
|
| Filtration | 1 | 2004 | 14 | 0.060 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 181 | 0.060 |
Why?
|
| Solvents | 1 | 2004 | 99 | 0.060 |
Why?
|
| Muscle, Smooth | 1 | 2004 | 58 | 0.060 |
Why?
|
| Thrombosis | 1 | 2004 | 63 | 0.060 |
Why?
|
| Bradykinin | 1 | 2003 | 22 | 0.060 |
Why?
|
| Thromboembolism | 1 | 2003 | 13 | 0.060 |
Why?
|
| Histamine | 1 | 2003 | 18 | 0.060 |
Why?
|
| Physics | 1 | 2023 | 2 | 0.060 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2003 | 13 | 0.060 |
Why?
|
| Blood Pressure Determination | 1 | 2003 | 52 | 0.060 |
Why?
|
| Head | 1 | 2023 | 27 | 0.060 |
Why?
|
| Skin | 1 | 2004 | 174 | 0.060 |
Why?
|
| Sulfates | 1 | 2022 | 23 | 0.050 |
Why?
|
| ADP Ribose Transferases | 1 | 2002 | 6 | 0.050 |
Why?
|
| Botulinum Toxins | 1 | 2002 | 11 | 0.050 |
Why?
|
| Maleimides | 1 | 2002 | 13 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2002 | 35 | 0.050 |
Why?
|
| Solutions | 1 | 2002 | 62 | 0.050 |
Why?
|
| Nitrites | 1 | 2002 | 46 | 0.050 |
Why?
|
| Cyclic GMP | 1 | 2002 | 47 | 0.050 |
Why?
|
| Ventricular Pressure | 1 | 2002 | 7 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 282 | 0.050 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2002 | 19 | 0.050 |
Why?
|
| Dogs | 1 | 2002 | 149 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 129 | 0.050 |
Why?
|
| Perfusion | 2 | 2012 | 33 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2002 | 131 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 2002 | 155 | 0.050 |
Why?
|
| Indoles | 1 | 2002 | 158 | 0.050 |
Why?
|
| Transfection | 2 | 2015 | 523 | 0.050 |
Why?
|
| Stochastic Processes | 1 | 2019 | 10 | 0.040 |
Why?
|
| Female | 5 | 2022 | 20969 | 0.040 |
Why?
|
| Antithrombins | 1 | 2016 | 3 | 0.040 |
Why?
|
| Heparin | 1 | 2016 | 35 | 0.030 |
Why?
|
| Hair | 1 | 2015 | 20 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 142 | 0.030 |
Why?
|
| Lysosomes | 1 | 2015 | 91 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 189 | 0.030 |
Why?
|
| Fluoresceins | 1 | 2015 | 27 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 260 | 0.030 |
Why?
|
| Phosphoproteins | 2 | 2008 | 163 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 220 | 0.030 |
Why?
|
| Kinetics | 1 | 2015 | 708 | 0.030 |
Why?
|
| Cations | 1 | 2010 | 45 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 2010 | 9 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2008 | 35 | 0.020 |
Why?
|
| Electroporation | 1 | 2008 | 18 | 0.020 |
Why?
|
| Lung | 1 | 2010 | 446 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2005 | 9 | 0.020 |
Why?
|
| Models, Structural | 1 | 2005 | 9 | 0.020 |
Why?
|
| Resins, Synthetic | 1 | 2005 | 1 | 0.020 |
Why?
|
| Solubility | 1 | 2005 | 118 | 0.020 |
Why?
|
| Mechanics | 1 | 2005 | 3 | 0.020 |
Why?
|
| Photography | 1 | 2005 | 46 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2005 | 76 | 0.020 |
Why?
|
| DNA | 1 | 2008 | 574 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2004 | 43 | 0.020 |
Why?
|
| Equipment Design | 1 | 2004 | 124 | 0.010 |
Why?
|
| Carbon | 1 | 2005 | 105 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 2003 | 3 | 0.010 |
Why?
|
| Colchicine | 1 | 2003 | 15 | 0.010 |
Why?
|
| Particle Size | 1 | 2004 | 215 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2003 | 50 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 550 | 0.010 |
Why?
|
| Thapsigargin | 1 | 2002 | 7 | 0.010 |
Why?
|
| Ryanodine | 1 | 2002 | 4 | 0.010 |
Why?
|